Resources

Type of publications
Regions
Diseases

5192 results found

2025 ∙ ATAGI

ATAGI statement on the administration of COVID-19 vaccines in 2025

  • Recommendation
  • Western Pacific
  • Australia
  • COVID-19
Download:
2025 ∙ ATAGI

ATAGI statement on the administration of seasonal influenza vaccines in 2025

  • Recommendation
  • Western Pacific
  • Australia
  • Influenza
Download:
2025 ∙ Folkhälsomyndigheten

Vaccination against mpox – a second update of vaccine recommendations due to increased spread of mpox clade 1

  • Recommendation
  • Europe
  • Sweden
  • Mpox
Download:
2025 ∙ Conseil Supérieur de la Santé (CSS)

Vaccination against Yellow Fever in Belgium

  • Recommendation
  • Europe
  • Belgium
  • Yellow fever
Download:
2025 ∙ NACI

Rapid response: Preliminary guidance on human vaccination against avian influenza in a non-pandemic context as of December 2024

  • Recommendation
  • Americas
  • Canada
Download:
2025 ∙ CAVEI

CAVEI recommendation on annual vaccination against COVID-19 for the year 2025

  • Recommendation
  • Americas
  • Chile
  • COVID-19
2025 ∙ NACI

Guidance on the use of COVID-19 vaccines for 2025 to summer 2026

  • Recommendation
  • Americas
  • Canada
  • COVID-19
Download:
2025 ∙ Global NITAG Network

Standard Operating Procedures of the Global NITAG Network

Download:
2024 ∙ Nangsue, C. Srisurapanont, K. Sudjaritruk, T.

A Comparison of the Immunogenicity and Safety of an Additional Heterologous versus Homologous COVID-19 Vaccination among Non-Seroconverted Immunocompromised Patients after a Two-Dose Primary Series of mRNA Vaccination: A Systematic Review and Meta-Analysis

  • All age groups
  • COVID-19
  • Efficacy/effectiveness
  • Safety
  • Administration
Methodological quality (AMSTAR 2):
Low
2024 ∙ Ewongwo, A. Sahor, A. F. Ngwa, W. Nwachukwu, C.

A guide to global access to HPV vaccination to all women in low- and middle-income countries; a minireview of innovation and equity

  • All age groups
  • Low and Middle Income Countries
  • Human papillomavirus (HPV)
  • Acceptance
Methodological quality (AMSTAR 2):
Not applicable
Loading...